Cipta Sarana Medika Tbk. vs Niramas Utama Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Niramas Utama Tbk. trades at Rp1,035 (market cap 1.37T, 198.78M 24h volume). The key difference: Niramas Utama Tbk. is far larger — about 8.7× Cipta Sarana Medika Tbk.'s market cap, and Niramas Utama Tbk. is more actively traded (198.78M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | JELI | |
|---|---|---|
Market Cap | 158.12B | 1.37T |
Volume | 8.21M | 198.78M |
Lot | 82.15K | 1.99M |
Turnover | 515.2M | 210.48B |
Average Price | 62.72 | 1,058.87 |
Value | 515.2M | 210.48B |
Indicative Equilibrium Price | 63 | 1,035 |
Indicative Equilibrium Volume | 1.33K | 22.32K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →